Arizona SB1716 modifies clozapine treatment protocols for psychiatric patients.

Arizona SB1716 amends state statutes to modify clozapine treatment protocols for psychiatric patients. It mandates that health insurers provide reimbursement for clozapine and prohibit rationing or denying access based on factors unrelated to the patient's clinical condition. The bill allows patients to waive or modify routine hematological monitoring with informed consent. It also ensures continuity of clozapine treatment, prohibits providers from discharging or penalizing patients for exercising their rights, and mandates that providers document any decision to withhold clozapine.

Arizona SB1716 modifies clozapine treatment protocols for psychiatric patients.

Arizona SB1716 amends state statutes to modify clozapine treatment protocols for psychiatric patients. It mandates that health insurers provide reimbursement for clozapine and prohibit rationing or denying access based on factors unrelated to the patient's clinical condition. The bill allows patients to waive or modify routine hematological monitoring with informed consent. It also ensures continuity of clozapine treatment, prohibits providers from discharging or penalizing patients for exercising their rights, and mandates that providers document any decision to withhold clozapine.